Ai+ clinical trial patient recruitment ｜ massive bio completed round a financing of $9million

2022 year 6 month 3 Japan , A registered leader in patient-centered clinical trials supported by precision medicine and artificial intelligence Massive Bio Announced the raising of funds 900 Thousands of dollars , from Revo Capital and Kenan Turnacıoğlu PaigeAI Jointly lead the investment , German development finance institutions DEG And get involved .

This investment will enable the company to further expand its global business , Invest in marketing , And use its rich data platform to launch more products in oncology clinical trial registration .

Massive Bio There are tens of thousands of active cancer clinical trials around the world , And dozens of biomarkers and precision oncology molecules , The aim is to leverage artificial intelligence and patient-centered Services , Worldwide exposure to cancer patients , And accelerate oncology research and infrastructure development .